Hyosung Corp. on Friday reported its second-quarter net income of 15.1 billion won (US$10.9 million), up 349.5 percent from a year earlier.

Operating profit

Samsung Bioepis Co., a biosimilar medicine developer under Samsung Group, has released its biosimilar product for autoimmune disease treatment Stelara in Europe, the company’s

Hyosung Advanced Materials Corp. on Friday reported its second-quarter net profit of 26.2 billion won (US$18.9 million), up 88.7 percent from a year earlier.

Lee Sang-in, acting chief of South Korea’s state broadcasting regulator, voluntarily stepped down Friday ahead of the National Assembly’s planned vote on his impeachment

Today (%) Previous Session(%) Change (BP)

1-year TB 3.193 3.203 -1.0

2-year TB 3.100 3.103 -0.3

3-year TB 3.024 3.024 0.0

10-year TB 3.108

A man in his 30s has filed a complaint against actor Yoo Ah-in, claiming the actor raped him while he was asleep, police said